In parallel to these physiological and microstructural changes, network level studies reveal decreased brain volumes in patients with disrupted SHANK3 expression, while SYNGAP1-DEE patients have generally normal imaging with high penetrance of epilepsy. This evidence concerns the gene SYNGAP1 and epilepsy.